| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |